SpyBiotech publishes preclinical SpyVector findings in JHEP Reports
SpyBiotech publishes preclinical SpyVector findings in JHEP Reports 19 October 2026 SpyBiotech has published new preclinical SpyVector findings in JHEP Reports. The study, “Therapeutic vaccination strategy targeting the PreS1 region of L-HBsAg for HBV/HDV co-infection,” investigated a recombinant adenoviral vaccine combining PreS1 surface display with encoded HBV antigens. Vaccination in mice generated HBV- and HDV-neutralising
SpyBiotech publishes preclinical SpyVector findings in JHEP Reports Read More »